Peter Kaiser, MD

216.444.2030

Peter Kaiser, MD
Department: Ophthalmology
Location: Cleveland Clinic Main Campus
Mail Code i32
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2030
DeskDesk:216.444.7152
WorkFax:216.445.8475
Surgeon:
Yes
Treats:
Adults Only

Biographical Sketch

Peter K. Kaiser, MD, is a Staff member of the vitreoretinal faculty of the Cole Eye Institute in the Department of Ophthalmology at Cleveland Clinic's main campus. He was appointed in 1997. Dr. Kaiser is the Founding Director of the Digital Optical Coherence Tomography (OCT) Reading Center at the Cole Eye Institute.

Dr. Kaiser received his medical degree magna cum laude from Harvard Medical School in Boston, Mass. He completed an internship in internal medicine at Massachusetts General Hospital, an ophthalmology residency at the Massachusetts Eye and Ear Infirmary in Boston and a retinal fellowship at Bascom Palmer Eye Institute in Miami, Florida.

Actively involved in retinal clinical research, Dr. Kaiser is study chairman of 4 major, multi-center, international clinical trials and is a principal investigator in multiple other trials. Complementing his research endeavors, Dr. Kaiser serves on numerous scientific advisory boards and addresses his research interests as an invited speaker at national and international conferences. 

Dr. Kaiser is a major contributor to medical literature having authored several ophthalmology texts, and more than 200 book chapters, original reports, electronic publications and abstracts. He is an associate editor of the American Journal of Ophthalmology, and serves on the editorial boards of Retina, Retina Today, Retinal Physician and Ocular Surgery News.

Dr. Kaiser has been recognized by the American Academy of Ophthalmology and American Society of Retina Specialists with Achievement and Senior Achievement Awards, and is listed in the "Best Doctors in America" list. He is the team ophthalmologist for the Cleveland Browns (National Football League), Cleveland Cavaliers (National Basketball Association) and the Cleveland Indians (Major League Baseball).

Professional Highlights

  • Editor-in-Chief, Current Concepts in Retina
  • Founding Director, Digital OCT Reading Center (DOCTR)
  • Associate Editor, American Journal of Ophthalmology
  • Editorial board, Retina, Retina Today, Retinal Physician, Ocular Surgery News
  • Associate Editor,  International Ophthalmology Clinics

Education & Fellowships

Fellowship - Bascom Palmer Eye Institute-Anne Bates Leach Eye Hospital
Ophthalmology
Miami, FL USA
1997
Residency - Massachusetts Eye and Ear Infirmary
Ophthalmology
Boston, MA USA
1996
Internship - Massachusetts General Hospital
Internal Medicine
Boston, MA USA
1993
Medical School - Harvard Medical School
Boston, MA USA
1992
Undergraduate - Harvard University
Biology
Cambridge, MA USA
1988

Certifications

  • Ophthalmology

Specialty Interests

Epiretinal membranes, vitreomacular traction, macular holes, age-related macular degeneration, Diabetic retinopathy, Retinal Detachment, vitreoretinal diseases

Awards & Honors

  • American Academy of Ophthalmology Senior Achievement Award (Senior Honor Award), 2008
  • National Institute of Health, RO1 grant funding, 2005-present
  • Who's Who in Executives and Professionals Listing National Register, West Islip NY, 2004- present
  • American Society of Retina Specialists, Senior Achievement Award (Senior Honor Award), 2003
  • American Society of Retina Specialists, Achievement Award (Honor Award), 2002
  • Best Doctors in America listing, 2002 - present
  • Best Doctors in Midwest listing, 2002-present
  • Best Doctors in Cleveland listing, 2002-present
  • American Academy of Ophthalmology Achievement Award (Honor Award), 2001
  • Strathmore's Who's Who listing, 2000-present
  • Study Chairman, DENALI Phase 3 Study
  • Study Chairman, VERITAS Phase 3 Study
  • Study Chairman, VIO Phase 3 Study
  • Study Chairman, TargeGen Phase 1 Study

Additional Training

  • FELLOWSHIP:  Bascom Palmer Eye Institute
                                Miami Florida    
                                Medical retina and vitreoretinal surgery  1996-1997
  • RESIDENCY:    Massachusetts Eye and Ear Infirmary    1993-1996
                                Boston, MA
                                Ophthalmology
  • INTERNSHIP:    Massachusetts General Hospital        1992-1993
                                Boston MA
                                Internal Medicine
  • MEDICAL SCHOOL:       Harvard Medical School        1988-1992
                                                Boston MA
                                                Doctor of Medicine
  • COLLEGE:        Harvard College            1984-1988
                                Boston MA
                                Bachelor of Arts

Innovations & Patents

  • Pioneer in the use of, and developer of several new 23 gauge surgical techniques, which allow sutureless vitrectomy surgery with less pain and faster visual recovery or patients
  • Pioneer in new vitrectomy systems that offer better flow rates, faster cutting speeds, and safer probes than current machines
  • First MD to use a modified RNA interfering molecule to treat age-related macular degeneration; this technique and its technology was the first time it had been used in any disease after the discovery of RNAi received the Nobel Prize in Medicine
  • Pioneer in the use of spectral domain optical coherence tomography in the diagnosis and management of vitreoretinal diseases

Memberships

  • Retina Society, 2003- present
  • Pan-American Ophthalmology Association, 2000- present
  • American Society of Retina Specialists (Vitreous Society), 2000 - present
  • Cleveland Ophthalmological Society, 1997 - present
  • International Academy of Sports Vision, 1997 - present

Treatment & Services

  • Clinical Trials
  • Diabetic Eye Examinations
  • Fluorescein Angiography
  • Intravitreal Injections For Retinal Disease
  • Laser For Diabetic Retinopathy
  • Laser Treatment Of Retinal Disease
  • Macular Degeneration Evaluations
  • Optical Coherence Tomography
  • Pars Plana Vitrectomy
  • Scleral Buckle

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/24/2013, Dr. Kaiser has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Kaiser received fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Alcon, Inc.
  • Bayer AG
  • Novartis International, AG
  • Oraya Therapeutics, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • ThromboGenics NV
  • Valeant Pharmaceuticals International, Inc.

Equity. Dr. Kaiser owns stock or stock options in the following companies for activities as a founder, inventor, discover, developer:

  • SKS Ocular, LLC

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site